Skip to content
TBC
lls
  • Home
  • All Episodes
    • CAR T-cell Therapy
    • Leukemia
    • Lymphoma
    • Myelodysplastic Syndromes
    • Myeloma & Amyloidosis
    • Pediatric and AYA
    • General Treatment & Support
  • Subscribe by Email
  • About
  • FAQs
  • Visit LLS.org

Category Archives: CAR T-cell Therapy

CAR-T in 2025: Advancements and the Road Ahead

Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX

CAR T-cell Therapy in 2024

Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO

Highlights from attending the 2023 ASH Annual Meeting

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

CAR T-cell Therapy in Review 2022: Updates in Treatment

Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX

CAR T-cell Therapy in 2022: What You Need to Know Part II

Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX

CAR T-cell Therapy in 2022: What You Need to Know

Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA

Post navigation

1 2 Next »

Categories

  • All Episodes (101)
  • CAR T-cell Therapy (11)
  • Clinical Trials (4)
  • COVID-19 (7)
  • General Treatment & Support (34)
  • Genomics (3)
  • Health Equity (8)
  • Leukemia (22)
  • Lymphoma (15)
  • Minimal Residual Disease (MRD) (4)
  • Myelodysplastic Syndromes (6)
  • Myeloma & Amyloidosis (14)
  • Myeloproliferative Neoplasms (4)
  • Pediatric and AYA (13)
  • Rare Blood Cancers (4)
  • Transplantation (4)
  • Waldenström macroglobulinemia (2)

Find us on your favorite podcatchers

Apple PodcastsSpotifyAmazon MusicAndroidiHeartRadioJioSaavnPodchaserPodcast Indexby EmailRSSMore Subscribe Options
For a complete listing of continuing education programs, visit www.LLS.org/CE     |      Disclaimer
2024 Treating Blood Cancers Podcast Series – The Leukemia & Lymphoma Society